Literature DB >> 29390884

Does Medical Expansion Improve Population Health?

Hui Zheng1, Linda K George2.   

Abstract

Medical expansion has become a prominent dynamic in today's societies as the biomedical model becomes increasingly dominant in the explanation of health, illness, and other human problems and behavior. Medical expansion is multidimensional and represented by expansions in three major components of the healthcare system: increasing medical investment, medical professionalization/specialization, and the relative size of the pharmaceutical industry. Using Organisation for Economic Co-operation and Development health data and World Development Indicators 1981 to 2007, we find medical investment and medical professionalization/specialization significantly improve all three measures of life expectancy and decrease mortality rate even after controlling for endogeneity problems. In contrast, an expanded pharmaceutical industry is negatively associated with female life expectancy at age 65 and positively associated with the all-cause mortality rate. It further compromises the beneficial effect of medical professionalization/specialization on population health. In general, medical professionalization/specialization and gross domestic product per capita have similar and stronger effects than medical investment.

Entities:  

Keywords:  expanded pharmaceutical industry; medical expansion; medical investment; medical professionalization/specialization; population health

Mesh:

Year:  2018        PMID: 29390884      PMCID: PMC5946318          DOI: 10.1177/0022146518754534

Source DB:  PubMed          Journal:  J Health Soc Behav        ISSN: 0022-1465


  40 in total

1.  Health care spending as determinants of health outcomes.

Authors:  P Y Crémieux; P Ouellette; C Pilon
Journal:  Health Econ       Date:  1999-11       Impact factor: 3.046

2.  The McKeown thesis: a historical controversy and its enduring influence.

Authors:  James Colgrove
Journal:  Am J Public Health       Date:  2002-05       Impact factor: 9.308

3.  An interpretation of the decline of mortality in England and Wales during the twentieth century.

Authors:  T McKeown; R G Record; R D Turner
Journal:  Popul Stud (Camb)       Date:  1975-11

4.  Flushed away.

Authors:  Jeffrey Kluger
Journal:  Time       Date:  2010-04-12

5.  The impact of new drug launches on longevity: evidence from longitudinal, disease-level data from 52 countries, 1982-2001.

Authors:  Frank R Lichtenberg
Journal:  Int J Health Care Finance Econ       Date:  2005-03

6.  The shifting engines of medicalization.

Authors:  Peter Conrad
Journal:  J Health Soc Behav       Date:  2005-03

7.  The relationship between health care expenditure and health outcomes. Evidence and caveats for a causal link.

Authors:  John Nixon; Philippe Ulmann
Journal:  Eur J Health Econ       Date:  2006-03

8.  Does health care spending improve health outcomes? Evidence from English programme budgeting data.

Authors:  Stephen Martin; Nigel Rice; Peter C Smith
Journal:  J Health Econ       Date:  2007-12-25       Impact factor: 3.883

9.  A critical theory of medical discourse: how patients and health professionals deal with social problems.

Authors:  H Waitzkin; T Britt
Journal:  Int J Health Serv       Date:  1989       Impact factor: 1.663

10.  Analyzing whether countries are equally efficient at improving longevity for men and women.

Authors:  Douglas Barthold; Arijit Nandi; José M Mendoza Rodríguez; Jody Heymann
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

View more
  2 in total

1.  Zheng and Echave Respond to "Population Health in Peril".

Authors:  Hui Zheng; Paola Echave
Journal:  Am J Epidemiol       Date:  2021-11-02       Impact factor: 5.363

2.  American Indian and Non-Hispanic White Midlife Mortality Is Associated With Medicaid Spending: An Oklahoma Ecological Study (1999-2016).

Authors:  Mark A Brandenburg
Journal:  Front Public Health       Date:  2020-04-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.